The Company reported net income of approximately $47,000 or $0.01 per basic and diluted common share for the three months ended February 28, 2026, compared to net income of approximately $283,000, or ...

Direct access to custom cell banks made from authenticated ATCC cell lines. Custom cell banking under cell culture quality standards approved by ATCC. Improved assay precision by the use of ...

Stem cells form the backbone of many cell-based therapies due to their unique properties, including the ability to self-renew and differentiate to many cell types. Multiple cell therapies deliver ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Clearbridge ...

acCELLerate produces custom cell banks, MCBs, WCBs and assay ready instaCELLs for drug discovery and bioassay in biologics potency testing. acCELLerate, a manufacturer of assay-ready frozen cells has ...